NCT01254578 2017-09-25Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersNational Cancer Institute (NCI)Phase 1 Completed17 enrolled
NCT00031941 2012-03-15CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed
NCT01116154 2010-12-09Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Terminated30 enrolled